Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I am positive, it could raise the sp exponentially over time, but given the ordeal all holders have had recently, it would have been nice if the buyer was in effect a ready to go operation. John Palmer is clearly a turnaround expert. Check his LinkedIn profile, so this will be another turnaround project. I cannot see this 50 or 10 bagging anytime soon. It appears the drawing board maybe be back out for our main and only product. Fingers crossed they get it right this time
Wishing to join telegram??
Well I tell you what leer, I think we should be thankful for small miracles at this stage and not start to look at the negatives ALREADY!!!! GLA here's hoping we at least get our initial investment back and then some
Good news but it is still very smoke and mirrors? Out of all the possibles it went to a related party? Given they have already said it needs a massive fund raise to run further trials, I’m presuming they are super confident of raising this amount. The new guy has some history starting bio firms and selling them on so I’m presuming that’s their plan here. Mainly because I can’t see anything else they could do???? Where does all this leave the share price???
@bobbyfirmino
Told you!
“ As consideration for the Transaction, Motif will receive the nominal amount of US$1 in addition to an interest in revenue that is derived from Motif Inc's iclaprim asset. Pursuant to the terms of the SPA, if Motif Inc generates revenue from the iclaprim asset above its outstanding liabilities, Motif Inc shall retain the first US$250,000 in revenue and thereafter, 90 per cent of any additional revenue will be paid to the Company, and the remaining 10 per cent of any additional revenue will be retained by Motif Inc.”
Hold these figures up against our market cap.
Like I’ve argued for months (feels like years) we did still own iclaprim
: )
RTO with a UK-based antibody drug conjugate discovery and development company. All the rage now a days, so the potential is there to recoup our investment and some cream on top of that!
Seems we might get sthg back for iclaprim after all. More importantly, it helps clear the way for the RTO.
Really does sound like it's going to happen. Hope our shares are relisted at a decent value.
GLA.